REPORT OUTLOOK
Market Size | CAGR | Dominating Region |
---|---|---|
USD 2.10 billion | 7.35% | Europe |
By Product | By Modality | By Application |
---|---|---|
|
|
|
SCOPE OF THE REPORT
Market Overview
The global continuous renal replacement therapy market is expected to grow at 7.35% CAGR from 2022 to 2029. It is expected to reach above 2.10 USD billion by 2029 from 1.13 USD billion in 2020.
Continuous renal replacement therapy (CRRT) is a popular treatment for critically ill patients with acute kidney injury, particularly those who are hemodynamically unstable. Continuous venovenous hemofiltration with mostly convective solute clearance, continuous venovenous haemodialysis with predominantly diffusive solute clearance, and continuous venovenous hemodiafiltration, which combines dialysis with hemofiltration, are all procedures that can be utilised. While CRRT was originally designed as an arteriovenous therapy, the majority of it is currently delivered via pump-driven venovenous extracorporeal circuits.
Although this adds some complexity, such as pressure monitors and air detectors, the pump-driven venovenous circuit provides higher and more regular blood flows while eliminating the risks associated with extended arterial cannulation with a large-bore catheter. Several methods for administering CRRT have been devised.
ATTRIBUTE | DETAILS |
Study period | 2020-2029 |
Base year | 2021 |
Estimated year | 2022 |
Forecasted year | 2022-2029 |
Historical period | 2018-2020 |
Unit | Value (USD Million) |
Segmentation | By Product, By Modality, By Age Group, By Region |
 By Product |
|
Â
By Modality  |
|
By Application  |
|
By Region  |
|
Furthermore, several reasons, including an increase in the global frequency of AKI, an increase in the number of ICU patients with AKI and an increase in the incidence of sepsis, and the growing therapeutic advantage of CRRT over intermittent blood purification, are expected to drive market expansion. Also, the existence of well-established major players focused on developing and commercializing technologically sophisticated products, as well as government initiatives to raise awareness about CRRT, are expected to drive market expansion throughout the forecast period.
Emerging economies including China, India, Brazil, and Mexico are likely to provide considerable growth opportunities for CRRT market participants. To capitalize on the considerable growth potential in emerging markets, firms are increasingly focused on strategic innovations that will enhance their presence in these markets and allow them to reach a large number of customers. Also, due to less stringent data requirements, regulatory regulations in the Asia Pacific area are more adaptable and business friendly. This, combined with increased competition in mature countries (Europe, Japan, and Australia), will drive CRRT product makers to concentrate on emerging markets.
However, the high procedural cost of CRRT restricts its demand and acceptance in both poor and rich nations. CRRT is a highly specialized and important therapy that necessitates extensive nursing care. ICU nurses must be properly trained. Yet, there is currently a shortage of licensed nurses in ICU settings. Furthermore, the intricacy of CRRT is anticipated to restrict market expansion. The increasing number of complications associated with CRRT has hampered and challenged the market growth.
The COVID-19 pandemic spread throughout the world and that disrupted the supply chain globally. Due to lockdown, the production process of all end-use industries was halted, closed or diverted towards recovering the covid patients and that significantly impacted the continuous renal replacement therapy market. Now the world markets have opened-up and it is expected to gain potential growth in continuous renal replacement therapy market.
Even the COVID-19 epidemic has resulted in an increase in demand for CRRT globally. The large number of activities undertaken by manufacturers and the government during the pandemic to raise awareness about CRRT and CKD are projected to fuel the growth of the market for continuous renal replacement therapy. As a result, financial incentives and regulatory assistance from various government agencies have increased in the market for continuous renal replacement treatment. These factors are projected to contribute to the global positive growth of the CRRT market over the forecast period.
Continuous Renal Replacement Therapy Market Segment Analysis
The global continuous renal replacement therapy market is segmented by product, modality, age group, and region.
Based on product segment, the continuous renal replacement therapy market includes Dialysates and Replacement Fluids, Disposables, Hemofilters, Bloodline Sets & Tubes, Other Disposables, CRRT Systems. The dialysates and replacement fluid category is expected to have the biggest market share. This sector has the greatest market share due to reasons such as rising demand for dialysates to remove unwanted solutes and restore electrolytes and acid-base balance in the blood, as well as the existence of well-established competitors with strong offers in dialysates and replacement fluids.
The continuous renal replacement therapy market can be classified based on the modality that is Continuous venovenous hemofiltration (CVVH), Continuous venovenous hemodiafiltration (CVVHDF), Continuous venovenous haemodialysis (CVVHD), Slow continuous ultrafiltration (SCUF). Â During the projection period, the continuous venovenous hemodiafiltration (CVVHDF) market is expected to expand at the fastest pace of any CRRT modality. The CVVHDF segment’s rapid rise can be ascribed to its versatility in comparison to other CRRT modalities. Another important aspect driving its expansion is the CVVHDF modality’s ability to combine the benefits of convection and diffusion for solute removal.
Based on age group segment, the continuous renal replacement therapy market includes Adults, Pediatrics /Neonates. The growing demand for invisible braces among adults is attributable to a large adult population with AKI, a rise in hospitalization among adults, and a huge availability of CRRT systems and disposables for adults having CRRT operation.
Continuous Renal Replacement Therapy Market Players
The global continuous renal replacement therapy market key players include Baxter International Inc., Fresenius Medical Care AG & Co. KGaA, NIKKISO CO., LTD., B. Braun Melsungen AG, Asahi Kasei Corporation, Toray Medical Co., Ltd., Infomed SA, Medtronic plc, Medica S.p.A., Medical Components, Inc., Medites Pharma spol. s.r.o., and others.
Various businesses are focusing on organic growth tactics such as new launches, product approvals, and other things like patents and events. Mergers &Â Acquisitions, partnerships, and collaborations were among the inorganic growth tactics observed in the market. These initiatives such as developing new products and upgrading others, have paved the road for market participants to expand their business. These market players in the continuous renal replacement therapy market are expected to benefit from attractive growth prospects in the future.
Moreover, an increase in public-private funding for target research activities, regulatory approval of an increasing number of contrast agents, and rising product innovations and development as a result of technological advancements all over the world will provide profitable opportunities for market players during the forecast period.
Who Should Buy? Or Key stakeholders
- Government and research organization
- Investors
- Trade Associations
- Healthcare Industry
- Scientific research organization
- Diagnostic center’s
Continuous Renal Replacement Therapy Market Regional Analysis
The continuous renal replacement therapy market by region includes North America, Asia-Pacific (APAC), Europe, South America, and Middle East & Africa (MEA).
- North America: includes the US, Canada, Mexico
- Asia Pacific: includes China, Japan, South Korea, India, Australia, ASEAN and Rest of APAC
- Europe: includes UK, Germany, France, Italy, Spain, Russia, and Rest of Europe
- South America: includes Brazil, Argentina and Rest of South America
- Middle East & Africa: includes Turkey, UAE, Saudi Arabia, South Africa, and Rest of MEA
Europe has a dominating share in the global continuous renal replacement therapy market due to rising incidence and prevalence of AKI and key market players present in the region. Followed by APAC which is highest growing market.
Key Market Segments: Continuous Renal Replacement Therapy Market
Continuous Renal Replacement Therapy Market by Product, 2020-2029, (USD Million)
- Dialysates And Replacement Fluids
- Disposables
- Hemofilters
- Bloodline Sets & Tubes
- Other Disposables
- CRRT Systems
Continuous Renal Replacement Therapy Market by Modality, 2020-2029, (USD Million)
- Continuous Venovenous Hemofiltration (CVVH)
- Continuous Venovenous Hemodiafiltration (CVVHDF)
- Continuous Venovenous Haemodialysis (CVVHD)
- Slow Continuous Ultrafiltration (SCUF)
Continuous Renal Replacement Therapy Market By Age Group, 2020-2029, (USD Million)
- Adults
- Pediatrics /Neonates
Continuous Renal Replacement Therapy Market By Region, 2020-2029, (USD Million)
- North America
- Europe
- Asia Pacific
- South America
- Middle East And Africa
Important Countries In All Regions Are Covered
Key Question Answered
- What is the current size of the continuous renal replacement therapy market?
- What are the key factors influencing the growth of continuous renal replacement therapy?
- What is the major end-use industry for continuous renal replacement therapy?
- Who are the major key players in the continuous renal replacement therapy market?
- Which region will provide more business opportunities for continuous renal replacement therapy in future?
- Which segment holds the maximum share of the continuous renal replacement therapy market?
Table of Content
- Introduction
- Market Definition
- Market Segmentation
- Research Timelines
- Assumptions and Limitations
- Research Methodology
- Data Mining
- Secondary Research
- Primary Research
- Subject-Matter Experts’ Advice
- Quality Checks
- Final Review
- Data Triangulation
- Bottom-Up Approach
- Top-Down Approach
- Research Flow
- Data Sources
- Data Mining
- Executive Summary
- Market Overview
- Global Continuous Renal Replacement Therapy Market Outlook
- Market Drivers
- Market Restraints
- Market Opportunities
- Impact of Covid-19 On Continuous Renal Replacement Therapy Market
- Porter’s five forces model
- Threat from new entrants
- Threat from substitutes
- Bargaining power of suppliers
- Bargaining power of customers
- Degree of competition
- Industry value chain Analysis
- Global Continuous Renal Replacement Therapy Market Outlook
- Global Continuous Renal Replacement Therapy Market by Product
- Dialysates And Replacement Fluids
- Disposables
- Hemofilters
- Bloodline Sets & Tubes
- Other Disposables
- CRRT Systems
- Global Continuous Renal Replacement Therapy Market by Modality
- Continuous Venovenous Hemofiltration (CVVH)
- Continuous Venovenous Hemodiafiltration (CVVHDF)
- Continuous Venovenous Haemodialysis (CVVHD)
- Slow Continuous Ultrafiltration (SCUF)
- Global Continuous Renal Replacement Therapy Market by Age Group
- Adults
- Pediatrics /Neonates
- Global Continuous Renal Replacement Therapy Market by Region
- North America
- US
- Canada
- Mexico
- South America
- Brazil
- Argentina
- Colombia
- Rest Of South America
- Europe
- Germany
- UK
- France
- Italy
- Spain
- Russia
- Rest Of Europe
- Asia Pacific
- India
- China
- Japan
- South Korea
- Australia
- South-East Asia
- Rest Of Asia Pacific
- Middle East and Africa
- UAE
- Saudi Arabia
- South Africa
- Rest Of Middle East and Africa
- North America
- Company Profiles* (Business Overview, Company Snapshot, Products Offered, Recent Developments)
-
-
- BAXTER INTERNATIONAL INC.
- FRESENIUS MEDICAL CARE AG & CO. KGAA
- NIKKISO CO., LTD.
- BRAUN MELSUNGEN AG
- ASAHI KASEI CORPORATION
- TORAY MEDICAL CO., LTD.
- INFOMED SA
- MEDTRONIC PLC
- MEDICA S.P.A.
- MEDICAL COMPONENTS, INC.
- MEDITES PHARMA SPOL. S.R.O. *The Company List Is Indicative
-
LIST OF TABLES
TABLE 1Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 2Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 3Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 4Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY REGION (USD MILLIONS) 2020-2029
TABLE 5Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 6Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 7Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â US CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 8Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 9Â Â Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 10Â Â Â Â Â Â Â Â Â Â Â Â Â CANADA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 11Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 12Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 13Â Â Â Â Â Â Â Â Â Â Â Â Â MEXICO CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 14Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 15Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 16Â Â Â Â Â Â Â Â Â Â Â Â Â BRAZIL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 17Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 18Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 19Â Â Â Â Â Â Â Â Â Â Â Â Â ARGENTINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 20Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 21Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 22Â Â Â Â Â Â Â Â Â Â Â Â Â COLOMBIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 23Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 24Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 25Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF SOUTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 26Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 27Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 28Â Â Â Â Â Â Â Â Â Â Â Â Â INDIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 29Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 30Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 31Â Â Â Â Â Â Â Â Â Â Â Â Â CHINA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 32Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 33Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 34Â Â Â Â Â Â Â Â Â Â Â Â Â JAPAN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 35Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 36Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 37Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH KOREA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 38Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 39Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 40Â Â Â Â Â Â Â Â Â Â Â Â Â AUSTRALIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 41Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 42Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 43Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH-EAST ASIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 44Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 45Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 46Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF ASIA PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 47Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 48Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 49Â Â Â Â Â Â Â Â Â Â Â Â Â GERMANY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 50Â Â Â Â Â Â Â Â Â Â Â Â Â UK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 51Â Â Â Â Â Â Â Â Â Â Â Â Â UK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 52Â Â Â Â Â Â Â Â Â Â Â Â Â UK CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 53Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 54Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 55Â Â Â Â Â Â Â Â Â Â Â Â Â FRANCE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 56Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 57Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 58Â Â Â Â Â Â Â Â Â Â Â Â Â ITALY CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 59Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 60Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 61Â Â Â Â Â Â Â Â Â Â Â Â Â SPAIN CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 62Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 63Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 64Â Â Â Â Â Â Â Â Â Â Â Â Â RUSSIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 65Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 66Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 67Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 68Â Â Â Â Â Â Â Â Â Â Â Â Â UAE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 69Â Â Â Â Â Â Â Â Â Â Â Â Â UAE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 70Â Â Â Â Â Â Â Â Â Â Â Â Â UAE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 71Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 72Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 73Â Â Â Â Â Â Â Â Â Â Â Â Â SAUDI ARABIA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 74Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 75Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 76Â Â Â Â Â Â Â Â Â Â Â Â Â SOUTH AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
TABLE 77Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT (USD MILLIONS) 2020-2029
TABLE 78Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY (USD MILLIONS) 2020-2029
TABLE 79Â Â Â Â Â Â Â Â Â Â Â Â Â REST OF MIDDLE EAST AND AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP (USD MILLIONS) 2020-2029
LIST OF FIGURES
FIGURE 1Â Â Â Â Â Â Â MARKET DYNAMICS
FIGURE 2Â Â Â Â Â Â Â MARKET SEGMENTATION
FIGURE 3Â Â Â Â Â Â Â REPORT TIMELINES: YEARS CONSIDERED
FIGURE 4Â Â Â Â Â Â Â DATA TRIANGULATION
FIGURE 5Â Â Â Â Â Â Â BOTTOM-UP APPROACH
FIGURE 6Â Â Â Â Â Â Â TOP-DOWN APPROACH
FIGURE 7Â Â Â Â Â Â Â RESEARCH FLOW
FIGURE 8Â Â Â Â Â Â Â GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY PRODUCT, USD MILLION, 2020-2029
FIGURE 9Â Â Â Â Â Â Â GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY MODALITY, USD MILLION, 2020-2029
FIGURE 10Â Â Â Â Â Â Â GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY AGE GROUP, USD MILLION, 2020-2029
FIGURE 11Â Â Â Â Â Â GLOBAL CONTINUOUS RENAL REPLACEMENT THERAPY MARKET BY REGION, USD MILLION, 2020-2029
FIGURE 12       PORTER’S FIVE FORCES MODEL
FIGURE 13Â Â Â Â Â Â Â NORTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SNAPSHOT
FIGURE 14Â Â Â Â Â Â Â EUROPE CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SNAPSHOT
FIGURE 15Â Â Â Â Â Â Â ASIA PACIFIC CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SNAPSHOT
FIGURE 16Â Â Â Â Â Â Â SOUTH AMERICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SNAPSHOT
FIGURE 17Â Â Â Â Â Â Â MIDDLE EAST & AFRICA CONTINUOUS RENAL REPLACEMENT THERAPY MARKET SNAPSHOT
FIGURE 18Â Â Â Â BAXTER INTERNATIONAL INC.: COMPANY SNAPSHOT
FIGURE 19Â Â Â Â Â Â Â FRESENIUS MEDICAL CARE AG & CO. KGAA: COMPANY SNAPSHOT
FIGURE 20Â Â Â Â Â Â Â NIKKISO CO., LTD.: COMPANY SNAPSHOT
FIGURE 21Â Â Â Â Â Â Â B. BRAUN MELSUNGEN AG: COMPANY SNAPSHOT
FIGURE 22Â Â Â Â Â Â Â ASAHI KASEI CORPORATION: COMPANY SNAPSHOT
FIGURE 23Â Â Â Â Â Â Â TORAY MEDICAL CO., LTD.: COMPANY SNAPSHOT
FIGURE 24Â Â Â Â Â Â Â INFOMED SA: COMPANY SNAPSHOT
FIGURE 25Â Â Â Â Â Â Â MEDTRONIC PLC: COMPANY SNAPSHOT
FIGURE 26Â Â Â Â Â Â Â MEDICA S.P.A.: COMPANY SNAPSHOT
FIGURE 27Â Â Â Â Â Â Â MEDICAL COMPONENTS, INC.: COMPANY SNAPSHOT
FIGURE 28Â Â Â Â Â Â Â MEDITES PHARMA SPOL. S.R.O.: COMPANY SNAPSHOT
FAQ
The Continuous Renal Replacement Therapy market size had crossed USD 1.13 billion in 2020 and will observe a CAGR of more than 7.35% up to 2029 driven by the increase in the global frequency of AKI and an increase in the number of ICU patients with AKI.
Europe accounted for a 41% share of the continuous renal replacement therapy market in 2020 and is expected to maintain its dominance during the forecast period.
Increase in the global frequency of AKI, an increase in the number of ICU patients with AKI and an increase in the incidence of sepsis, and the growing therapeutic advantage of CRRT over intermittent blood purification, are expected to drive market expansion. Emerging economies including China, India, Brazil, and Mexico are likely to provide considerable growth opportunities for CRRT market participants. But the increasing number of complications associated with CRRT has hampered and challenged the market growth.
Rising incidence and prevalence of AKI, as well as advantageous reimbursement regulations in the Europe region, it accounted for a large share of continuous renal replacement therapy market in 2020 and is expected to maintain its dominance during the forecast period.
Due to its large patient population base with AKI, quick development of the healthcare sector and rising disposable income, high utilization of CRRT and emergence of manufacturer’s in APAC, it is expected to have the highest CAGR in coming years.
In-Depth Database
Our Report’s database covers almost all topics of all regions over the Globe.
Recognised Publishing Sources
Tie ups with top publishers around the globe.
Customer Support
Complete pre and post sales
support.
Safe & Secure
Complete secure payment
process.